Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential. [electronic resource]
Publication details: Therapeutic advances in chronic disease Jan 2018Description: 33-50 p. digitalISSN:- 2040-6223
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.